Advancing Precision Medicine Through Trajectory Intelligence
“Detect early. Act early. Preserve Brain Health, for life.”
“We believe that clinical trial failure is not an inevitability of neurodegeneration, but a limitation of how we measure human disease. Our mission is to transform patient heterogeneity from an unmeasured risk into a mathematically mastered asset.”
Leadership Team
Uniting world-renowned computational neuroscientists, clinical neurologists, and pharmaceutical trial executives across Paris and New York.
Stanley Durrleman, PhD
Distinguished researcher in AI and computational neurosciences. Pioneered dynamic disease modeling over 15+ years at the Paris Brain Institute (ICM) before founding Qairnel. Alumnus of École Polytechnique.
Kuno van der Post, PhD
30+ years of commercial and business development leadership in life sciences. Former executive leader deploying large-scale digital health technologies and clinical software for top-tier pharma at Medidata Solutions and ActiGraph.
Prof. Audrey Gabelle, MD, PhD
Professor of Neurology and internationally recognized Key Opinion Leader in dementia and Alzheimer’s research. Formerly led digital neurology research at Biogen (including pioneer collaborative initiatives with Apple).
Helena Mistry, PhD
Leading strategic alliances with pharmaceutical sponsors and clinical development teams across the US and European biopharma ecosystems.
Global Presence & Ecosystem
Paris Brain Institute (ICM) & Station F
Paris Headquarters: Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière & Station F (Care Forward Program led by Roche, Doctolib and Paris Hospitals (AP-HP)).
New York, NY
US Operations: New York, NY. Supporting North American pharmaceutical sponsors, Clinical Development VPs, and FDA regulatory covariate alignment across Phase II and Phase III neuroscience trials.
Join Our Computational Neuroscience & Biostatistics Teams
We recruit senior biostatisticians, Riemannian geometry & machine learning researchers, and clinical trial leads in Paris and New York. Connect directly with our executive team.